This report examines reimbursement challenges limiting adoption of digital diabetes technologies such as continuous glucose monitors, insulin delivery systems, and decision-support tools. Despite strong evidence of clinical and economic benefit, fragmented coverage policies, complex billing rules, and lack of reimbursement for provider time hinder uptake. The report outlines short- and long-term policy solutions, including modernized CPT codes, expanded telehealth coverage, and value-based reimbursement models. It concludes that aligning incentives across payers, providers, and manufacturers is critical to fully integrating digital diabetes care into routine practice.

Join for free to read